BRGXOTCServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31

BIOREGENX, INC.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 20, 2026

$0.00+0.00 (0.00%)

Close on Oct 16, 2026

Market cap: $3.88M
P/E (TTM): –
Dividend yield: –

BIOREGENX, INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31
Cash & Equivalents	0.07	0.06	0.13	0.62	0.02	0.09
Cash & Short-Term Investments	0.07	0.06	0.13	0.62	0.02	0.09
Receivables	0.04	0.01	0.10	–	–	–
Inventory	0.11	0.11	0.22	–	–	–
Prepaid Expenses & Other	0.04	0.12	0.21	–	–	–
Other Current Assets	0.03	0.12	0.14	–	–	–
Total Current Assets	0.25	0.31	0.65	0.00	0.02	–
Property, Plant & Equipment	0.16	0.20	0.01	–	–	–
Goodwill	–	–	0	–	–	–
Intangible Assets	–	0	0.05	0.04	0.04	–
Other Long-Term Assets	–	0	0.15	–	–	–
Total Assets	0.41	0.51	0.87	0.06	0.13	–
Accounts Payable	0.62	0.43	0.24	–	–	–
Accrued Expenses	0.43	0.45	0.35	–	–	–
Current Portion of Long-Term Debt	1.00	0.88	0.20	0.00	0.00	–
Current Debt	1.00	0.88	0.20	0.00	0.00	–
Deferred Revenue (Current)	0.06	0.20	0.35	–	–	–
Total Current Liabilities	4.07	3.63	2.79	0.06	0.01	–
Long-Term Debt	0.18	0.25	0.15	0.20	0.20	–
Total Liabilities	4.95	3.89	2.94	0.26	0.21	–
Total Debt	1.19	1.14	0.35	0.20	0.20	–
Preferred Stock	–	–	0.00	–	–	–
Common Stock	0.97	0.96	0.77	0.27	0.27	–
Additional Paid-In Capital	32	31	9.68	2.44	2.44	–
Retained Earnings	-37	-36	-13	-2.92	-2.80	–
Comprehensive Income & Other	0	0.00	0.00	–	–	–
Shareholders' Equity	-4.54	-3.38	-2.07	-2.53	-0.08	0.18
Total Equity	-4.54	-3.38	-2.07	-2.53	-0.08	0.18
Total Liabilities & Equity	0.41	0.51	0.87	0.06	0.13	–
Shares Outstanding(shares)	969	957	771	270	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, TTM

Gross margin: 81.9%
Operating margin: -62.4%
Net margin: -73.8%
Return on equity, FY2025: 39.0%

Financial strength

Current ratio: 0.05
Debt to equity: -0.04
Debt to assets: 54.2%
Cash to current liabilities: 1.1%

Valuation

P/E ratio: –
Price to sales: 2.20
Price to book: –
Dividend yield: –